{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:25:17Z","timestamp":1761488717576},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T00:00:00Z","timestamp":1308873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1746-1596-6-57","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T18:19:15Z","timestamp":1308939555000},"source":"Crossref","is-referenced-by-count":6,"title":["Very low prevalence of epidermal growth factor receptor (EGFR) protein expression and gene amplification in Saudi breast cancer patients"],"prefix":"10.1186","volume":"6","author":[{"given":"Mohamed A","family":"Shawarby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalal M","family":"Al-Tamimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,24]]},"reference":[{"key":"431_CR1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, Bell DW, Sordella R, et al.: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004, 350: 2129-2139. 10.1056\/NEJMoa040938.","journal-title":"N Engl J Med"},{"key":"431_CR2","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG, Janne PA, Lee JC, et al.: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004, 304: 1497-1500. 10.1126\/science.1099314.","journal-title":"Science"},{"key":"431_CR3","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.0405220101","volume":"101","author":"W Pao","year":"2004","unstructured":"Pao W, Miller V, Zakowski M, et al.: EGF receptor gene mutations are common in lung cancers from 'never smokers' and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA. 2004, 101: 13306-13311. 10.1073\/pnas.0405220101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"431_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0022-4731(89)90072-1","volume":"34","author":"AL Harris","year":"1989","unstructured":"Harris AL, Nicholson S, Sainsbury JR, et al.: Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu. J Steroid Biochem. 1989, 34: 123-131. 10.1016\/0022-4731(89)90072-1.","journal-title":"J Steroid Biochem"},{"key":"431_CR5","first-page":"3454","volume":"8","author":"S Tsutsui","year":"2002","unstructured":"Tsutsui S, Kataoka A, Ohno S, et al.: Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer. Clin Cancer Res. 2002, 8: 3454-3460.","journal-title":"Clin Cancer Res"},{"key":"431_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1023\/A:1006194700667","volume":"53","author":"RA Walker","year":"1999","unstructured":"Walker RA, Dearing SJ: Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas. Breast Cancer Res Treat. 1999, 53: 167-176. 10.1023\/A:1006194700667.","journal-title":"Breast Cancer Res Treat"},{"key":"431_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/modpathol.3800438","volume":"18","author":"R Bhargava","year":"2005","unstructured":"Bhargava R, Gerald WL, Li AR, et al.: EGFR gene amplification in breast cancer: correlation with epidermal growth factor mRNA and protein expression and Her-2 status and absence of EGFR-activating mutations. Modern Pathology. 2005, 18: 1027-1033. 10.1038\/modpathol.3800438.","journal-title":"Modern Pathology"},{"key":"431_CR8","volume-title":"J Clin Oncol","author":"MF Press","year":"2008","unstructured":"Press MF, Finn RS, Di Leo A, et al.: Correlation of HER2 gene amplification, HER2 and EGFR expression (protein and mRNA) with lapatinib efficacy in women with metastatic breast cancer. J Clin Oncol. 2008, 26: (May 20 suppl; abstr 1007)"},{"key":"431_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/annonc\/mdl322","volume":"18","author":"D Generali","year":"2007","unstructured":"Generali D, Leek R, Fox SB, et al.: EGFR mutations in exons 18-21 in sporadic breast cancer. Ann Oncol. 2007, 18: 203-205.","journal-title":"Ann Oncol"},{"key":"431_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/1471-2407-10-376","volume":"10","author":"Z Liang","year":"2010","unstructured":"Liang Z, Zhang J, Zeng X, et al.: Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas. BMC cancer. 2010, 10: 376-10.1186\/1471-2407-10-376.","journal-title":"BMC cancer"},{"key":"431_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/1471-2407-10-223","volume":"10","author":"DM Al Tamimi","year":"2010","unstructured":"Al Tamimi DM, Shawarby MA, Ahmed A, et al.: Protein expression profile and prevalence pattern of the molecular classes of breast cancer - a Saudi population based study. BMC Cancer. 2010, 10: 223-10.1186\/1471-2407-10-223.","journal-title":"BMC Cancer"},{"key":"431_CR12","doi-asserted-by":"publisher","first-page":"R1028","DOI":"10.1186\/bcr1341","volume":"7","author":"JS Reis-Filho","year":"2005","unstructured":"Reis-Filho JS, Milanezi F, Carvalho S, et al.: Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromagenic in situ hybridization analysis. Breast Cancer Research. 2005, 7: R1028-R1035. 10.1186\/bcr1341.","journal-title":"Breast Cancer Research"},{"key":"431_CR13","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.humpath.2006.04.015","volume":"37","author":"MJ Kim","year":"2006","unstructured":"Kim MJ, Ro JY, Ahn SH, et al.: Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and HER2\/neu-overexpressing phenotypes. Hum Pathol. 2006, 37: 1217-1226. 10.1016\/j.humpath.2006.04.015.","journal-title":"Hum Pathol"},{"key":"431_CR14","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, et al.: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006, 295: 2492-2502. 10.1001\/jama.295.21.2492.","journal-title":"JAMA"},{"key":"431_CR15","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/jnci\/djp082","volume":"101","author":"MCU Cheang","year":"2009","unstructured":"Cheang MCU, Chia SK, Voduc D, et al.: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer. J Natl Cancer Inst. 2009, 101: 736-750. 10.1093\/jnci\/djp082.","journal-title":"J Natl Cancer Inst"},{"key":"431_CR16","first-page":"444","volume":"2","author":"R Bhargava","year":"2009","unstructured":"Bhargava R, Striebel J, Beriwal S, et al.: Prevalence, Morphologic Features and Proliferation Indices of Breast Carcinoma Molecular Classes Using Immunohistochemical Surrogate Markers. Int J clin Exp Pathol. 2009, 2: 444-455.","journal-title":"Int J clin Exp Pathol"},{"key":"431_CR17","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1186\/bcr2128","volume":"10","author":"RM Tamimi","year":"2008","unstructured":"Tamimi RM, Baer HJ, Marotti J, et al.: Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Research. 2008, 10: R67-10.1186\/bcr2128.","journal-title":"Breast Cancer Research"},{"key":"431_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10549-007-9694-5","volume":"110","author":"CA Adebamowo","year":"2007","unstructured":"Adebamowo CA, Famooto A, Ogundiran TO, et al.: Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast cancer research and treatment. 2007, 110: 183-188.","journal-title":"Breast cancer research and treatment"},{"key":"431_CR19","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/modpathol.3800408","volume":"18","author":"K Al-Kuraya","year":"2005","unstructured":"Al-Kuraya K, Schraml P, Sheikh S, et al.: Predominance of high-grade pathway in breast cancer development of Middle East women. Modern Pathology. 2005, 18: 891-897. 10.1038\/modpathol.3800408.","journal-title":"Modern Pathology"},{"key":"431_CR20","first-page":"507","volume":"29","author":"SN Bin Amer","year":"2008","unstructured":"Bin Amer SN, Magbool Z, Nirmal MS, et al.: Gene expression profiling in women with breast cancer in a Saudi population. Saudi Med J. 2008, 29: 507-513.","journal-title":"Saudi Med J"},{"key":"431_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/01913120903183135","volume":"33","author":"DM Al-Tamimi","year":"2009","unstructured":"Al-Tamimi DM, Bernard PS, Shawarby MA, et al.: Distribution of molecular breast cancer subtypes in Middle Eastern-Saudi Arabian women: A pilot study. Ultrastructural Pathology. 2009, 33: 141-150.","journal-title":"Ultrastructural Pathology"},{"issue":"4","key":"431_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02787207","volume":"15","author":"EM Ibrahim","year":"1998","unstructured":"Ibrahim EM, al-Mulhim FA, al-Amri A, al-Muhanna FA, Ezzat AA, Stuart RK, Ajarim D: Breast cancer in the Eastern province of Saudi Arabia. Med Oncol. 1998, 15 (4): 241-247. 10.1007\/BF02787207.","journal-title":"Med Oncol"},{"issue":"2","key":"431_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF02785842","volume":"16","author":"AA Ezzat","year":"1999","unstructured":"Ezzat AA, Ibrahim EM, Raja MA, Al-Sobhi S, Rostom A, Stuart RK: Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Med Oncology. 1999, 16 (2): 95-103. 10.1007\/BF02785842.","journal-title":"Med Oncology"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-6-57.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1746-1596-6-57\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1746-1596-6-57.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T23:56:59Z","timestamp":1548115019000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/1746-1596-6-57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,24]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["431"],"URL":"https:\/\/doi.org\/10.1186\/1746-1596-6-57","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,24]]},"article-number":"57"}}